Education
About Us
Working with TipRanks
Follow Us
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
Standard Lymphodepletion Regimen
Stiff-Person Syndrome, Sps
Phase II
Recruiting
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome
Sep 06, 2024
―
Kyv-101 Anti-Cd19 Car-T Cell Therapy, Standard Lymphodepletion Regimen
Lupus Nephritis, Lupus Nephritis - Who Class Iii, Lupus Nephritis - Who Class Iv
Phase I/II
Recruiting
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
Mar 27, 2024
―
Standard Lymphodepletion Regimen, Kyv-101, Anti-Cd20 Mab
Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive, Ms
Phase II
Active Not Recruiting
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
Nov 21, 2023
―
Standard Lymphodepletion Regimen, Kyv-101, Standard Of Care Treatment
Generalized Myasthenia Gravis, Myasthenia Gravis
Phase II/III
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Oct 11, 2023
―
Standard Lymphodepletion Regimen, Kyv-101
Systemic Sclerosis, Systemic Sclerosis - Diffuse Cutaneous, Systemic Sclerosis - 2013 Acr/Eular Classification Criteria
Phase I/II
Active Not Recruiting
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
Aug 29, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kyverna Therapeutics, Inc. (KYTX) have in its pipeline
KYTX is currently developing the following drugs: Standard Lymphodepletion Regimen, Kyv-101 Anti-Cd19 Car-T Cell Therapy, Standard Lymphodepletion Regimen, Standard Lymphodepletion Regimen, Kyv-101, Anti-Cd20 Mab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.